A Key Special Report Lecture – Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared
Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared On November 21, 2024, the 15th special report […]
Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared On November 21, 2024, the 15th special report […]
Tangning Tongluo Tablets Approved to Directly Conduct Phase III Clinical Trials On November 12, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd.(hereinafter referred to as Beletalent) received